hemophilic

(redirected from hemophilic arthropathy)
Also found in: Dictionary, Thesaurus.
Related to hemophilic arthropathy: hemophilia

hemophilic

 [he″mo-fil´ik]
1. pertaining to hemophilia.
2. in bacteriology, growing well on culture media containing blood or having a nutritional requirement for constituents of fresh blood.

he·mo·phil·ic

(hē-mō-fil'ik),
Relating to hemophilia.

hemophilic

(hē′mə-fĭl′ĭk)
adj.
1. Of, relating to, or affected by hemophilia.
2. Growing well in blood or in a culture containing blood. Used of certain bacteria.

he·mo·phil·ic

(hē'mō-fil'ik)
Relating to hemophilia.
Synonym(s): haemophilic.
References in periodicals archive ?
A total of 61 hemophilia patients with hemophilic arthropathy of knee joints were managed at our hemophilia center.
This Pettersson scoring system has been adopted by the World Federation of Haemophilia as the preferred radiographic classification system for hemophilic arthropathy.
A significant reduction in pain from hemophilic arthropathy of knee was observed up to 6 months ( F = 35.32, P < 0.01), with the maximal benefit being noted at 2 months after HA injection [Figure 2].{Figure 2}
To the best of our knowledge, the present study is the first research to evaluate synovial thickness and hyperemia by the use of USG as therapeutic measurements in patients with hemophilic arthropathy after intra-articular HA injection.
Joshi et al., "Vascular remodeling underlies rebleeding in hemophilic arthropathy," American Journal of Hematology, vol.
von Drygalski, "Advances and challenges in hemophilic arthropathy," Seminars in Hematology, vol.
Hemophilic arthropathy is a degenerative joint disease occurring in patients with hemophilia and is caused by recurrent intra-articular bleeding.
TRM-201 (rofecoxib) is a highly potent COX-2 selective non-steroidal anti-inflammatory drug (NSAID) with a well-established efficacy profile and is the first and only product granted orphan designation status for the treatment for hemophilic arthropathy.
The company plans to develop and commercialize rofecoxib for the orphan indication of the treatment of hemophilic arthropathy and subsequent niche patient segments where it has a strong benefit to risk ratio versus other therapies.
Hemophilic arthropathy most commonly affects the large joints.
There is also some evidence that radionuclide synovectomy can help reduce hemarthrosis and prevent hemophilic arthropathy. (6) However, because of the progressive and irreversible nature of large joint involvement, total joint replacement remains the only effective treatment for end-stage disease.
Hemophilic arthropathy is a wellknown manifestation of hemophilia.